FLOWOOD, Miss. , Aug. 18, 2022 /PRNewswire/ -- Zavation Medical Products ("Zavation" or the "Company"), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the FDA 510K Clearance of Varisync™, a cervical intervertebral body fusion device.
Zavation Medical Products, LLC, receives FDA 510K Clearance for Varisync™ Anterior Cervical Plate and Spacer system as an addition to its cervical spine portfolio.
Varisync™, the most recent addition to the Zavation cervical spine portfolio, has been tested and approved for both the independent and synchronized use of its plate and spacer components. This allows Zavation's surgeon partners to use these plate and spacer options together as a system or pair individual components with any of Zavation's existing cervical portfolio options. The Varisync™ plate has been thoughtfully designed and boasts attributes that include visual and tactile confirmation of locks, ideal screw angulation, multiple insertion devices, and optimal spacer placement in the disc space.
Zavation's market share and active surgeon base continues to rapidly grow given the Company's ability to adapt to surgeon/patient needs, consistently upgrade its instruments, and engineer devices with incomparable simplicity and precision. Zavation's sustained investment in research and development will further enhance its technologies and accelerate market share and active surgeon base gains.
"Our product development team's dedication to creatively blending simplicity and precision in a robust product design has produced a product that we believe is the new gold standard in facilitating patient fusion in a seamless and simplified procedure," said Jeffrey Johnson, Chief Executive Officer "With the extensive interbody offerings that Zavation boasts, it only makes sense that we develop a device, that allows surgeons to easily integrate and place a plate and spacer combination of their choice." This product is an example of Zavation's commitment to offering innovative and differentiated products in conjunction with market leading customer service to best serve our surgeons and distributor network."
The VariSync™ Plate is intended for anterior screw fixation to the cervical spine (C2-C7) for the following indications: degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), trauma (including fractures), tumors, deformity (defined as kyphosis, lordosis, or scoliosis), pseudarthrosis, failed previous fusion, spondylolisthesis, and spinal stenosis.
The VariSync™ Spacer is an interbody fusion device intended for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine (C2-T1) at one level. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had at least six (6) weeks of non-operative treatment. The VariSync™ Spacer is to be filled with autograft or allogenic bone graft comprised of cancellous and/or corticancellous bone graft in skeletally mature patients. These devices are intended to be used with supplemental fixation such as the Zavation VariSync™ Plate, Zavation Midline Plate, Zavation EZ Plate, or Zavation Cervical Plate Systems. When used with the VariSync™ Plate, the assembly takes on the indications of the VariSync™ Spacer, with the VariSync™ Plate acting as the supplemental fixation.
ABOUT ZAVATION MEDICAL PRODUCTS, LLC.
Based in Flowood, MS, Zavation designs, engineers, and manufactures a portfolio of spinal hardware and biologics covering key areas including cervical, thoracolumbar, interbody fusion, interventional spine, and minimally invasive surgery. Founded in 2012, Zavation has experienced exceptional growth and created a national network of numerous distributors across the United States. The Company has commercialized over 25 product families since inception. Zavation operates a newly constructed 75,000 square foot vertically integrated facility in Flowood, MS. To learn more information about Zavation and the Company's suite of products, visit www.zavation.com.
Related Links www.zavation.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/zavation-medical-products-llc-receives-fda-510k-clearance-for-varisync-anterior-cervical-plate-and-spacer-system-as-an-addition-to-its-cervical-spine-portfolio-301608024.html
SOURCE Zavation Medical Products, LLC.
NFL simulation: How likely is it that the #Raiders will make the playoffs in 2022?
The Food and Drug Administration authorized Novavax Inc.'s COVID-19 vaccine for use in U.S. teenagers on Friday. Novavax's recombinant protein-based vaccine uses different technology than the mRNA shots developed by Moderna Inc. and BioNTech SE , and received an emergency-use authorization by the FDA for adults in July. The vaccine still requires a policy recommendation for use by the Centers for Disease Control, which followed the FDA by about a week when authorizing the Novavax shot for adults
Yahoo Finance's Brian Cheung discusses reports that a depression drug from Axsome Therapeutics has gotten FDA clearance.
The Food and Drug Administration approved a new depression pill from Axsome Therapeutics on Friday, and AXSM stock catapulted higher.
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received expanded emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a two-dose primary series for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus
U.S. based monkeypox vaccine manufacturer targets December for first batch of doses for delivery.
Sanofi (SNY) ends the development of breast cancer candidate, amcenestrant. Novartis' (NVS) lung cancer candidate, canakinumab fails a phase III study. FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) Lynparza sNDA.
Dr. Ilona Butova almost looks out of place in her neatly pressed lavender scrubs as she walks through a door frame that hangs from a crumbled wall into what used to be an administrative office of her hospital in Zolochiv. Since Russia's invasion on Feb. 24, space to treat patients at the hospital has shrunk constantly because of damage. Care is being provided in the hardest-hit areas by doctors who have refused to evacuate or have rushed in as volunteers, putting themselves at great risk.
"I do think he saved my life and so does everybody else around me," cat owner Sam Felstead told BBC
Get ready for a big change in how the U.S. will pay for COVID-19 vaccines and treatments. The Department of Health and Human Services is expected to hold a meeting later this month with drug makers, pharmacies, and state health departments to discuss moving coverage of pandemic therapies away from the U.S. government and into a commercial market, according to The Wall Street Journal. Arpa Garay, Moderna’s (MRNA) chief commercial officer, told investors on a recent earnings call that the company is already preparing for the evolution of the COVID-19 vaccine market.
The U.S. government asks Bavarian Nordic, the sole manufacturer of a monkeypox vaccine, to find new partners.
This Texas coffee shop is a one stop shop for a cup of joe and emergency contraceptives for those in need.
“Were you vaccinated for polio? Do you think I was vaccinated for polio,” I asked my boyfriend two nights ago, as a part of my typical daily concern rambling.
The U.S. Centers for Disease Control and Prevention had confirmed 851 cases of monkeypox in the state as of Tuesday. Here’s the latest on new cases and vaccines.
The White House said that in an effort to control the ongoing monkeypox outbreak, it will make vaccines available to health departments with large LGBTQ+ events.
The ads are everywhere — as are the inflated claims: Special shampoos and treatments, sometimes costing thousands of dollars, will make hair grow. But many dermatologists who specialize in hair loss say that most of these products do not work. “There is an endless array of useless hair-growth remedies,” often at “significant cost,” said Dr. Brett King, a dermatologist at Yale School of Medicine. Yet, he added, “because people are desperate, such hair growth remedies continue to abound.” But ther
A regular 12-ounce bottle of Mountain Dew soda contains 46 grams of added sugar (almost 4 tablespoons), while a diet soda contains zero grams of sugar and zero calories. So, it seems obvious that the diet Dew is the healthier choice—0 calories and sugar grams versus 46 sugar grams and 170 calories? It's lemons versus limes.But when you ask the question "what happens to my body when I drink that diet soda," the answer isn't so straightforward. So, let's pick through the pros and cons. 1 Pro: You
Late-stage cervical cancer rates are on the rise in the U.S. The steepest increases in white women, prevalence of the disease is still higher in Black women.
Boston Children’s Hospital and its Center for Gender Surgery are facing backlash over chest and genital gender-affirming surgeries following viral tweets from Libs of TikTok.
A Star-Telegram reader asked about birth control access for teenagers post-Roe v. Wade. Here’s what we found out.